This inventor holds 4 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Amgen Inc., Exelixis, Inc., Bristol-Myers Squibb Compnay. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2,074 
2 out of 177 
1 out of 3,745 
Years Active: 2014-2023
Title: The Innovative Contributions of Joon Won Jeong
Introduction
Joon Won Jeong is a notable inventor based in Belmont, California. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on developing innovative compounds and methods that have the potential to treat serious medical conditions.
Latest Patents
Among his latest patents is the invention of N-cyano-7-azanorbornane derivatives and their uses. This patent provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, along with pharmaceutical compositions that comprise this compound. It also outlines a method for manufacturing these compounds and their therapeutic uses. Another significant patent is related to KRAS G12C inhibitors, which includes compositions and methods for using these inhibitors. These inhibitors are particularly useful for treating various disorders, including pancreatic, colorectal, and lung cancers.
Career Highlights
Joon Won Jeong has worked with prominent companies in the pharmaceutical industry, including Amgen Inc. and Exelixis, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of cancer treatment.
Collaborations
Throughout his career, Joon has collaborated with esteemed colleagues such as Daniel A. Erlanson and Jeffrey Iwig. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Joon Won Jeong's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His innovative work continues to pave the way for new treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile